Cephalon Reduces Debt Levels
-
Font Size:
The company expects to book a related $20.8 million charge in its fourth quarter. As a results of the transactions, Cephalon reduced its 2007 outlook for basic adjusted income to $4.15 - $4.25 per share.
The company said its 2006 earnings and sales outlook remain unchanged, as does its 2007 sales forecast. In November, Cephalon projected 2006 sales of $1.66 billion to $1.68 billion and basic adjusted income of $5.10 to $5.20 per share. Sales in 2007 should range from $1.68 billion to $1.73 billion.
Also, Cephalon announced in December that the FDA would likely delay a final approval decision on its drug Nuvigil for excessive sleepiness, while the agency continues to investigate a case of a potentially serious skin rash seen with a related medicine. The company, however, reiterated its sales forecast for 2007 and does not expect a significant effect from this delay. They had expected to have a "modest" launch of Nuvigil, which is expected to replace Provigil once its patent expires.
Cephalon has done a great job of managing its product life cycle by developing Nuvigil and launching it before the Provigil patent expires.
CEPH stock is currently at $69.75 and trading at about 15X 2007 expected earnings and well off of its 52 week high of $82.92. I consider this level a great value for opening a position. The chart below shows a down side risk to $55 where the stock would be trading at Dirt Cheap prices. I think, given the relatively safe earnings prediction, as well as the new capital structure, that the stock has little risk of down side move, as long as the overall sector does not take a major hit.

Get Seeking Alpha Free Stock Alerts by Email!
Get Free Stock Alerts by Email!
-
Editor's Picks
-
Most Popular
- Russian Inflation: Is the Boom About To Bust?
- The Disastrous Future of the U.S.
- Is There a "Best Way" to Invest in Wind Power?
- Yahoo Partners with Getty Images: Strategic Shift for Image Search?
- Bank of America vs. Banco Santander: Whose Dividend Is Secure?
- Fannie, Freddie, and Financing Models of Last Resort
- Full list of Editor's Picks »
- 10 Top Dividend Stocks of the S&P 500 »
- The Screws Tighten on Apple Investors »
- Wall Street Breakfast: Must-Know News »
- The After Hours Oil Scam »
- Attention Apple Investors: Analysts You Don’t Know But Should »
- Sirius and XM Satellite Merger Set for Approval; RBC Lowers Price Targets »
- Coal Stocks: Where to From Here? »
- Sirius-XM Merger Decision Delay Is Unacceptable »
- Bargain Hunting: Stocks With Strong Earnings Growth »
- Stocks to Buy Before the Oil Bubble Bursts »
- Potash Corp. Looks Good on the Pullback »
-
Long Ideas
-
Short Ideas
-
Cramer's Picks
- Apple's iPhone to Capture Chinese Internet Market
- Nuclear Power's Second Coming Will Lead to a Uranium Boom
- Is Boeing Ready To Take Off?
- Biotech is Healthy - Fast Money Recap (7/8/08)
- Google's Still Good - Cramer's Lightning Round (7/8/08)
- The Sound of Silence in Financials - Cramer's Mad Money (7/8/09)
- Is GE Action a Sign of a Turn?
- Verasun Energy: Expect Future Growth and Profitability
- Who Will Crack the CIGS Nut in Thin Film?
- American Capital Strategies: Ride the Recovery
- Full list of Long Ideas »
- Red Flags at Typhoon Touch Technologies
- Risk/Reward of Owning REITs, Raymond James in this Boom Bust Cycle
- Sell and Short Recommendations for a Bearish Market
- Covering Down Some of My Short Positions
- What's Going on With uWink?
- Brokerage Stocks: Trouble on the Horizon?
- 5 Reasons Amphenol Will Have Trouble Exceeding Expectations
- Looking To Profit From the Market's Plunge
- Crystal River’s Q2 Write-Downs Could Bankrupt the Company
- Assurant Is A Compelling Short Sell
- Full list of Short Ideas »
- Biotech is Healthy - Fast Money Recap (7/8/08)
- Google's Still Good - Cramer's Lightning Round (7/8/08)
- The Sound of Silence in Financials - Cramer's Mad Money (7/8/09)
- More Pain for Petrohawk - Cramer's Lightning Round (7/7/08)
- Recession Season - Cramer's Mad Money (7/7/08)
- StanCorp a Safe Financial - Cramer's Lightning Round (7/2/08)
- Momentum Stocks Stalled - Cramer's Stop Trading! (7/3/08)
- Expecting a Lift for Pediatrix: Cramer's Mad Money (7/3/08)
- The Most Bullish Thing - Cramer's Stop Trading! (7/1/08)
- Exelon's Got Nukes - Cramer's Lightning Round (7/1/08)
- Full list of Cramers Picks »
Most Popular Feeds
-
ETFs
-
US Market
-
Long Ideas
-
Alt. Energy
- Full list of feeds »
Hedge Fund Jobs
Job Seekers:
- Search jobs by category
- Get job alerts by email or live feed
- Apply online
Employers
- See all recruitment options
- Get applications online or by email


